|
gptkbp:instanceOf
|
gptkb:drug
alpha-glucosidase inhibitor
|
|
gptkbp:approvedBy
|
1990s
|
|
gptkbp:ATCCode
|
A10BF01
|
|
gptkbp:availableOn
|
gptkb:tablet
|
|
gptkbp:brand
|
gptkb:Glucobay
Prandase
Precose
|
|
gptkbp:CASNumber
|
56180-94-0
|
|
gptkbp:contraindication
|
intestinal obstruction
inflammatory bowel disease
chronic intestinal diseases
|
|
gptkbp:developedBy
|
gptkb:Bayer_AG
|
|
gptkbp:effect
|
delays glucose absorption
|
|
gptkbp:eliminationHalfLife
|
2 hours
|
|
gptkbp:excretion
|
urine
feces
|
|
gptkbp:foundIn
|
gptkb:WHO_Model_List_of_Essential_Medicines
|
|
gptkbp:hasMolecularFormula
|
C25H43NO18
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
acarbose
|
|
gptkbp:interactsWith
|
oral hypoglycemic agents
digestive enzymes
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
inhibits intestinal alpha-glucosidases
|
|
gptkbp:metabolism
|
intestinal
|
|
gptkbp:molecularWeight
|
645.6 g/mol
|
|
gptkbp:pregnancyCategory
|
B3 (Australia)
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
diarrhea
abdominal pain
flatulence
|
|
gptkbp:usedFor
|
gptkb:type_2_diabetes_mellitus
|
|
gptkbp:bfsParent
|
gptkb:A10BX03
|
|
gptkbp:bfsLayer
|
6
|